"Designing Growth Strategies is in our DNA"

Transforming Growth Factor Beta (Tgf-Beta) Inhibitor – Pipeline Review, 2020

Various clinical studies have demonstrated the role of TGF-Beta family in the development and progression of various conditions including cancer, bone remodeling, and mus... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Upcoming | Report ID: FBI100903 | Status : Pipeline

 

Request PDF Brochure

Refresh Button
TGF-Beta Inhibitor Pipeline Review
  • Direct Purchase
  • 2050
    4150
    6150

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X